Blog Post

LabGenius Raises £35 Million In Series B Funding

See how Fusion helped LabGenius explain its machine-learning antibody discovery platform to investors ahead of a £35 million Series B raise.

Author:
Fiona Day
Published On:
Sep 2024
Updated On:
Sep 2026

Congratulations to LabGenius who recently announced a £35 million Series B fundraise.

We were approached by LabGenius to create a video demonstrating how they create drug candidates, how the drugs work at a molecular level and their benefits vs other formats. The goal was to help explain the unique ML-driven antibody discovery platform to investors.

[[video=791915983]]

[[related-case-study]]

Looking for something similar to help secure funding? Why not get in touch to find out how we can help you secure funding too.